Patent · US Active

Anti-VEGF protein compositions and methods for producing the same

US12202883B2 · kind B2 · utility

0Cited by
9References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 4, 2024
Grant dateJan 21, 2025
Priority date
Expiry dateJun 4, 2044

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2030/027
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure pertains to compositions comprising aflibercept and methods for producing such compositions in chemically defined media and using chromatography to reduce certain aflibercept variants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.